Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables RefundsShares Issued
Ratios

Ligand Pharmaceuticals (LGND) Amortization - Deferred Charges: 2010-2011

Historic Amortization - Deferred Charges for Ligand Pharmaceuticals (LGND) over the last 2 years, with Dec 2011 value amounting to $425,000.

  • Ligand Pharmaceuticals' Amortization - Deferred Charges changed negligibly% to $425,000 in Q4 2011 from the same period last year, while for Dec 2011 it was $1.7 million, marking a year-over-year change of. This contributed to the annual value of $1.7 million for FY2011, which is negligibly% changed negligibly from last year.
  • As of Q4 2011, Ligand Pharmaceuticals' Amortization - Deferred Charges stood at $425,000, which was down 0.23% from $426,000 recorded in Q3 2011.
  • In the past 5 years, Ligand Pharmaceuticals' Amortization - Deferred Charges ranged from a high of $426,000 in Q3 2010 and a low of $425,000 during Q2 2010.
  • Over the past 2 years, Ligand Pharmaceuticals' median Amortization - Deferred Charges value was $426,000 (recorded in 2011), while the average stood at $425,571.
  • Data for Ligand Pharmaceuticals' Amortization - Deferred Charges shows a peak YoY grew of 0.24% (in 2011) over the last 5 years.
  • Quarterly analysis of 2 years shows Ligand Pharmaceuticals' Amortization - Deferred Charges stood at $425,000 in 2010, then remained steady at $425,000 in 2011.
  • Its Amortization - Deferred Charges stands at $425,000 for Q4 2011, versus $426,000 for Q3 2011 and $426,000 for Q2 2011.